Characterization of bradykinin receptors in human lung fibroblast using the binding of [3H][Des-Arg10, LEU9]kallidid and [3H]NPC17731

Life Sciences

Volumn 62, Issue 25, 1998, Pages 2303-2314

  Zhang, Sui Po ^a   Codd, Ellen E ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Bradykinin; Human lung fibrobalst; Kallidin; NPC17731

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; DEUTERIUM; KALLIDIN[9 LEUCINE 10 DEARGININE]; MEMBRANE PROTEIN; NPC 17731; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; HUMAN; HUMAN CELL; LUNG FIBROBLAST;

BINDING, COMPETITIVE; CELL LINE; HUMANS; KALLIDIN; LUNG; MAGNESIUM CHLORIDE; MEMBRANE PROTEINS; OLIGOPEPTIDES; RADIOLIGAND ASSAY; RECEPTORS, BRADYKININ; SODIUM CHLORIDE; TRITIUM;

EID: 0032523881     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00211-2     Document Type: Article

References (36)

1. 1. W.T. BERALDO and S.P. ANDRADE, Discovery of bradykinin and the kallikrein-kinin system, S.G. Farmer (Ed), 1-8, Academic Press, San Diego, CA (1997).
2. 2. K.D. BHOOLA, C.D. FIGUEROA and K. WORTHY, Pharmacol. Rev. 44 1-80 (1992).
3. 3. A. DRAY and M. PERKINS, Trends Neurosci. 16 99-104 (1993).
4. 4. J.N. SHARMA and W.W. BUCHANAN, Exp. Toxicol. Pathol. 46 421-33 (1994).
5. 5. D. REGOLI and J. BARABE, Pharmacol. Rev. 32 1-46 (1980).
6. 6. T.A. VOINO-YASENETSKAYA, V.A. TKACHUK, E.G. CHEKNEVA, M.P. PANCHENKO, G.Y. GRIGORYAN, R.J. VAVREK, J.M. STEWART and U.S. RYAN, FASEB J. 3 44-51 (1989).
7. 7. RA. ROBERTS, Prog. Growth Factor Res. 1 237-52 (1989).
8. 8. T.L. LAMBERT, R.S. KENT and A.R. WHORTON, J. Biol. Chem. 261 15288-93 (1986).
9. 9. S.K. BUTT, L.G. DAWSON and J.M. HALL, Br. J. Pharmacol. 114 612-17 (1995).
10. 10. J.L. FIELD, S.K. BUTT, I.K.M. MORTON and J.M. HALL, Br. J. Pharmacol. 113 607-13 (1994).
11. 11. L.M.F. LEEB-LUNDBERG, X.-H. SONG and S.A. MATHIS, J. Biol. Chem. 269 24328-34 (1994).
12. 12. L. VACA, W.P. SCHILLING and D.L. KUNZE, Pfluegers Arch. 422 66-74 (1992).
13. 13. R.M. BURCH and J. AXELROD, Proc. Natl. Acad. Sci. U. S. A. 84 6374-8 (1987).
14. 14. S.I. BRIAND, S.G. BERNIER and G. GUILLEMETTE, J. Cell. Biochem. 63 292-301 (1996).
15. 15. C.R.J. KENNEDY, P.R. PROULX and R.L. HEBERT, Am. J. Physiol. 271 C1064-C1072 (1996).
16. 16. K.-M. LEE, Regulation of tyrosine phosphorylation and calcium entry by bradykinin, 115, Univ. of Chicago, Chicago, IL, USA (1995).
17. 17. V. VENEMA, M.B. MARRERO and R.C. VENEMA, Biochem. Biophys. Res. Commun. 226 703-710 (1996).
18. 18. J.G. MENKE, J.A. BORKOWSKI, K.K. BIERILO, T. MACNEIL, A.W. DERRICK, K.A. SCHNECK, R.W. RANSOM, C.D. STRADER, D.L. LINEMEYER and J.F. HESS, J. Biol. Chem. 269 21583-6 (1994).
19. 19. T. MACNEIL, K.K. BIERILO, J.G. MENKE and J.F. HESS, Biochim. Biophys. Acta 1264 223-8 (1995).
20. 20. P. MCINTYRE, E. PHILLIPS, E. SKIDMORE, M. BROWN and M. WEBB, Mol. Pharmacol. 44 346-55 (1993).
21. 21. J.F. HESS, J.A. BORKOWSKI, G.S. YOUNG, C.D. STRADER and R.W. RANSOM, Biochem. Biophys. Res. Commun. 184 260-8 (1992).
22. 22. A.E. MCEACHERN, E.R. SHELTON, S. BHAKTA, R. OBERNOLTE, C. BACH, P. ZUPPAN, J. FUJISAKI, R.W. ALDRICH and K. JARNAGIN, Proc. Natl. Acad. Sci. U.S.A. 88 7724-8 (1991).
23. 23. J.-X. MA, D.-Z. WANG, L. CHAO and J. CHAO, Gene 149 283-8 (1994).
24. 24. J.M. HALL and I.K.M. MORTON, The pharmacology and immunopharmacology of kinin receptors, S.G. Farmer (Ed), 9-43, Academic Press, San Diego, CA (1997).
25. 25. J.M. HALL, Gen. Pharmacol. 28 1-6 (1997).
26. 26. A. TRIFILIEFF, A. DA SILVA, Y. LANDRY and J.P. GIES, J. Pharmacol. Exp. Ther. 263 1377-82 (1992).
27. 27. L.M.F. LEEB-LUNDBERG, S.A. MATHIS and M.C.S. HERZIG, J. Biol. Chem. 269 25970-3 (1994).
28. 28. S. REISSMANN, C. SCHWUCHOW, L. SEYFARTH, L.F. PINEDA DE CASTRO, C. LIEBMANN, I. PAEGELOW, H. WERNER and J.M. STEWART, J. Med. Chem. 39 929-36 (1996).
29. 29. P.J. MUNSON and D. RODBARD, Anal. Biochem. 107 220-39 (1980).
30. 30. J.W. DEAR, K. WIRTH, G.K. SCADDING and J.C. FOREMAN, Br. J. Pharmacol. 119 1054-1062 (1996).
31. 31. R.M. BURCH, D.J. KYLE and T.M. STORMANN, Molecular biology and pharmacology of bradykinin receptors, 7-18, R.G. Landes Co., Austin, TX (1993).
32. 32. M.C.S. HERZIG and L.M.F. LEEB-LUNDBERG, J. Biol. Chem. 270 20591-8 (1995).
33. 33. S.G. FARMER and R.M. BURCH, Annu. Rev. Pharmacol. Toxicol. 32 511-36 (1992).
34. 34. D.G. SAWUTZ, D.M. FAUNCE, W.T. HOUCK and D. HAYCOCK, Eur. J. Pharmacol., Mol. Pharmacol. Sect. 227 309-15 (1992).
35. 35. S.B. PHAGOO, M. YAQOOB, M.C.S. BROWN and G.M. BURGESS, Br. J. Pharmacol. 119 863-868 (1996).
36. 36. J. BOUTHILLIER, D. DEBLOIS and F. MARCEAU, Br. J. Pharmacol. 92 257-64 (1987).